Pharmacare for all: the cost of delay
Dating as far back as the 1940s, at least seven different royal commissions, national fora, parliamentary committees, and citizen reference panels have studied this issue and recommended single-payer, universal pharmacare on clinical, ethical, and economic grounds.
It’s well known that Canada’s public, universal medicare coverage of physician and hospital services is a very cost-effective way of delivering care to Canadians. Repeated studies demonstrate that Canada’s medicare system delivers comparable service to private systems with lower per capita cos...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
